Altre lingue Adaptive Biotechnologies Corporation

Azioni

ADPT

US00650F1093

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 10/06/2024			Variaz. 5gg	Var. 1 gen.
3,49 ^USD	-3,32%		+5,44%	-28,78%

07/05	Adaptive Biotechnologies Corporation riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
07/05	Transcript : Adaptive Biotechnologies Corporation, Q1 2024 Earnings Call, May 07, 2024

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress	31/05
Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference	29/05
Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q1 Revenue $41.9M, vs. Street Est of $38.8M	07/05
Adaptive Biotechnologies: Q1 Earnings Snapshot	07/05
Adaptive Biotechnologies Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results	07/05
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024	17/04
Adaptive Biotechnologies Corporation Announces Preliminary Unaudited Revenue Results for the First Quarter Ended March 31, 2024	05/04
Adaptive Biotechnologies Corporation Announces CFO Changes	03/04
Adaptive Biotechnologies Reports Preliminary Q1 Revenue, Appoints Kyle Piskel as CFO	02/04
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue	02/04
Adaptive Biotechnologies Corporation Provides Revenue Guidance for the First Quarter Ended March 31, 2024	02/04
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024	27/03
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024	27/03
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference	22/02
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference	22/02
Adaptive Biotechnologies' Q4 Loss Widens; Revenue Declines; Shares Down	15/02
Adaptive Biotechnologies: Q4 Earnings Snapshot	14/02
Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q4 Revenue $45.8M, vs. Street Est of $48.5M	14/02
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results	14/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Adaptive Biotechnologies Corporation

Azioni

ADPT

US00650F1093

Altre lingue

Filtri